teriparatide 20 micrograms/day subcutaneous

DRUG3 trials

Sponsors

Eli Lilly and Company

Conditions

Osteoporosis, Post-MenopausalOsteoporosis, Postmenopausal

Phase 3

A Study of the Treatment of Postmenopausal Women With Osteoporosis

CompletedNCT00543023

Eli Lilly and CompanyOsteoporosis, Post-Menopausal

Start: 2003-06-30End: 2004-08-31Updated: 2007-10-12

PTH Comparison in Post Menopausal Women

CompletedNCT00543218

Eli Lilly and CompanyOsteoporosis, Post-Menopausal

Start: 2002-12-31End: 2004-06-30Updated: 2007-10-12

Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis

CompletedNCT00542984

Eli Lilly and CompanyOsteoporosis, Postmenopausal

Start: 2003-08-31End: 2004-11-30Updated: 2007-10-12